None of the three dozen sales of oil wells proposed in California this year has materialized due to the considerable clean-up costs for the wells estimated by the state’s oil and gas regulator.

Exegenesis Bio, a clinical stage global gene therapy company is pleased to announce that US FDA has granted Orphan Drug Designation ("ODD") to EXG110, a novel gene therapy for Fabry disease, a rare ...

It military devices in a retaliatory move against the United States for its own curbs on Chinese tech applications on Tuesday ...